NCT04779606View on ClinicalTrials.gov

Efficacy, Safety and Local Tolerability Study of Chloroprocaine 3% Gel Eye Drops in Healthy Volunteers

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

105

Participants

Timeline

Start Date

June 16, 2020

Primary Completion Date

October 13, 2020

Study Completion Date

October 20, 2020

Conditions

Healthy Subjects

Interventions

DRUG

Ocular gel

3 drops instilled in the right eye

Trial Locations (1)

Unknown

CROSS Research S.A., Arzo

All Listed Sponsors

lead

Sintetica SA

INDUSTRY

NCT04779606 - Efficacy, Safety and Local Tolerability Study of Chloroprocaine 3% Gel Eye Drops in Healthy Volunteers | Biotech Hunter | Biotech Hunter